G. Gaidano

New Frontiers in Monoclonal Antibodies for Relapsed/Refractory Diffuse Large B-Cell Lymphoma

A. Mahmoud, M. Schipani, G. Margiotta-Casaluci, 2023, Cancers.

Prior immune checkpoint inhibitor (ICI) therapy is associated with decreased COVID-19-related hospitalizations and complications in patients with cancer: Results of a propensity-matched analysis of the OnCovid registry.

L. Rimassa, A. Cortellini, D. Pinato, 2023, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Realizing precision medicine in chronic lymphocytic leukemia: Remaining challenges and potential opportunities

K. Stamatopoulos, T. Chatzikonstantinou, S. Pavlova, 2024, HemaSphere.

ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia—2024 update

K. Stamatopoulos, T. Chatzikonstantinou, S. Stilgenbauer, 2024, Leukemia.

Prognostication in chronic lymphocytic leukemia.

R. Moia, G. Gaidano, 2024, Seminars in hematology.

Current Therapeutic Sequencing in Chronic Lymphocytic Leukemia

Sreekar Kogila, S. Mouhssine, Nawar Maher, 2024, Hematology reports.

Monitoring Response and Resistance to Treatment in Chronic Lymphocytic Leukemia

I. Della Starza, I. Del Giudice, P. Sportoletti, 2024, Cancers.

CD49d expression is included in a revised 4‐factor model predicting outcome in patients with chronic lymphocytic leukemia treated with ibrutinib: A multicenter real‐world experience

A. Cuneo, R. Marasca, R. Moia, 2024, HemaSphere.

Progressive multifocal leucoencephalopathy after autologous bone marrow transplantation: a treatment option

G. Gaidano, R. Cantello, A. Stecco, 2011, BMJ Case Reports.

Targeting BTK in B Cell Malignancies: From Mode of Action to Resistance Mechanisms

A. Alwan, B. Matti, S. Mouhssine, 2024, International journal of molecular sciences.